Changzhou Cancer Hospital of Soochow University
2 clinical trials · Sponsor
◉ Watch Changzhou Cancer Hospital of Soochow University
| Record | Firm | Date |
|---|---|---|
| Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer (NCT04192682) | Changzhou Cancer Hospital of Soochow University | 2019-05-08 |
| An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer (NCT03129256) | Changzhou Cancer Hospital of Soochow University | 2016-12-01 |
Track Changzhou Cancer Hospital of Soochow University automatically
Every clearance here is in the API, with alerts when new ones post.